In the new filing, Lilly says it wants to wade into the legal proceedings to “protect its interests and help bring this suit to a swift end.” The company’s lawyers further contend that OFA ...

Lilly seeks to protect interests in compounded drug case FDA affirms no shortage of tirzepatide drugs Compounded versions cheaper, often not covered by insurers Jan 2 (Reuters) - Eli Lilly (LLY.N ...

Senior equity analysts at StockNews.com upgraded Eli Lilly (LLY, Financial) stock from 'hold' to 'buy' as its stock has shifted positively. Analysts say the upgrade is a sign of increased ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for ... [+] health insurers, employers and government health programs who cover it in 2025.

We're calling on #SAFC fans and our friends around the world to help support a fantastic cause - Sunderland Community Soup Kitchen. As the New Year dawns, we have plenty to reflect on from the ...

For the 25-year-old star of ‘Nosferatu’ and ‘The Idol,’ it's been critical to maintain privacy amid a growing spotlight Axelle/Bauer-Griffin/FilmMagic Lily-Rose Depp may be one of ...

Novo and Lilly have both been on a manufacturing expansion tear in 2024, lining up multiple high-profile production projects around the world. To name just a few investments, Novo has blueprinted ...

Lily-Rose Depp was born into Hollywood royalty ... When her co-star, Nicholas Hoult, admitted that red carpet appearances were "absolutely terrifying," Depp reassured him that it "means you ...

Eli Lilly has been riding the weight-loss drug wave. The company's weight-loss drugs have been shown to be more effective than rival Ozempic. The stock currently trades at an attractive valuation.